Application of EudragitR NM30D on Diclofenac Sodium Matrix Tablet

韩海岭,柴佩华,丁宇,王建新
DOI: https://doi.org/10.3969/j.issn.1006-0103.2008.04.009
2008-01-01
Abstract:OBJECTIVE New product Eudragit~ NM30D was used as matrix material to develop a formulation of diclofenac sodium sustained release tablet in order to simplify the formulation and production process and to investigate the properties of this polymer.METHODS Eudragit~ NM30D was used as binder and controlling agent in wet granulation process to prepare a dicolfenac sodium matrix tablet.The influence of polymer amount,types of fillers and particle size were studied.RESULTS Eudragit~ NM30D could be used as suslained-release matrix material in diclofenac sodium matrix tablet Also it could be directly used as a binder to simplify the wet granulation process.The formulation consisting of 10% polymer and lactose showed similar performance as a commercial product.CONCLUSION The advantages of Eudragit~ NM30D in matrix tablet are low polymer amount,simple formulation and robust process.
What problem does this paper attempt to address?